Stop Buying Equipment. Start Buying Verification.

Look, I'll save you the preamble. In medical device procurement, the single most expensive mistake isn't buying the wrong product—it's buying one you haven't properly verified. Over 4 years of reviewing deliverables for a medical device company, I've rejected nearly 12% of first-run manufacturing samples in 2024 alone. Not because the specs were wrong on paper, but because what the vendor *thought* they were building didn't match what we *knew* we needed.

This matters whether you're specifying a Coloplast Peristeen Plus irrigation system for a urology clinic, ordering bulk IV catheters for a hospital system, or evaluating the mechanical lifespan of a pacemaker lead. The product category changes; the principle doesn't.

Why Verification is the Product

I review roughly 200 unique production samples every year—from stoma bag adhesives to catheter coating samples. When I implemented our formal product verification protocol in 2022, the upfront cost felt painful. A $12,000 investment in testing rigs, third-party lab time, and documentation systems.

But here's what actually happened: our customer satisfaction scores on contract fulfillment jumped by 34% within twelve months. We stopped catching errors after they shipped. We caught them during the first sample review.

It's tempting to think a spec sheet tells you everything. It doesn't. Identical written specifications from different vendors—even on something as routine as a silicone catheter—can produce wildly different clinical outcomes. The surface finish might differ. The durometer (hardness) might be at the opposite end of the accepted tolerance range. The packaging seal integrity might fail at a slightly lower pressure.

The Peristeen Plus Example

A colleague once assumed 'same specification' meant identical results when sourcing a replacement component for the Coloplast Peristeen Plus irrigation system. Didn't verify the internal channel diameter of the replacement tubing. Turned out the 'equivalent' part had a 0.5mm difference in the internal passage—enough to alter the flow rate significantly. Cost the clinic a series of patient complaints and a $900 re-order of the correct parts. (Note to self: never assume 'equivalent' means 'identical.')

My Classic Mistake (You Probably Make It Too)

In my first year in quality, I made the classic rookie error: I approved a batch of 8,000 ostomy appliance flanges based on a single pre-production sample. The sample was perfect. The production run? The adhesive had been cured at a slightly lower temperature to speed up the line. In storage conditions, the bond degraded. We lost nearly $4,000 in inventory.

The truth is, the 'always get three quotes' advice ignores the transaction cost of vendor evaluation and the value of an established, verified relationship. On a 50,000-unit annual order for IV catheters, a 1% defect rate means 500 unusable units. A verification protocol that costs $0.02 per unit to catch that defect is cheaper than the field failure cost. Way cheaper.

How Does This Apply to Complex Devices?

Take something as complex as a pacemaker. You don't buy the device; you buy its performance over a decade. The 5-year mechanical survival rate is the product. The centrifuge-testing protocol for the internal transformer is the product. The insulation integrity under repeated flex is the product.

You need to verify the product exists. Here's what you need to know about building a verification protocol that actually works:

• Define the critical-to-quality parameters. Not all specs are equal. For a colostomy product, the adhesive wear time is critical. For a urology catheter, the tip geometry and lubricious coating uniformity are critical. Focus your testing budget there.
• Test the production run, not the prototype. Pre-production samples are often made by senior engineers on a clean bench. Production runs are made on a machine at 2 AM on a Tuesday. Verify the production process, not the laboratory capability.
• Build a 'first article' inspection into the contract. We now include a mandatory First Article Inspection (FAI) clause in every purchase order over $10,000. The vendor submits 3-10% of the first run for destructive and non-destructive testing before we authorize the full batch. Once, an FAI caught an IV catheter hub that had been assembled with the wrong type of medical-grade adhesive. That caught a defect that could have affected thousands of units.

What if the Vendor Pushes Back?

Honestly, if a vendor genuinely can't produce first-article samples for verification, that's a red flag. You'd be surprised how often 'we don't do that' actually means 'we can't guarantee our process output.' Most reputable manufacturers—including those who make components for Coloplast and similar companies—already do this internally. You're asking them to share the data.

The pushback is often about cost. A full FAI—including dimensional checks, material composition analysis, and functional testing—can add a few hundred dollars to the upfront cost of the first run. On a $20,000 catheter order, that's a 1-2% premium for certainty. I've rejected first deliveries costing $8,000 because the tensile strength of a seal was 3% below our internal spec. The vendor thought it was 'within industry standard.' Our spec said otherwise. They redid it at their cost. Now every contract includes batch-level tensile verification.

When Verification Doesn't Help (Honestly)

I need to be fair here. Verification isn't a magic bullet. It doesn't solve problems with poorly written specifications. If your spec says 'must be strong enough,' no verification protocol will save you. You need to translate 'strong enough' into 'minimum peel strength of 4.5 N/cm on a standardized test jig.'

Also, verification has diminishing returns. Testing 100% of an IV catheter batch is wasteful. You need a statistically valid sample size, not a warehouse full of destroyed samples. The sweet spot is around 3-8% of the batch, depending on the risk profile of the device.

Finally, verification doesn't fix a fundamentally bad product design. You can verify a badly designed pacemaker lead until you're blue in the face. It's still a badly designed lead. Verification is about process and conformance, not about validating a flawed concept.

Take it from someone who rejected 8,000 units of ostomy flanges because of a curing temperature variance: the money you spend on verification isn't a cost. It's an insurance premium against the cost of failure. And in medical devices, the cost of failure isn't just financial. It's patient safety.

(P.S. A quick tip for Coloplast Peristeen Plus users verifying your irrigation system components: always check the conical seal's Shore A durometer. A seal that's too hard won't compress properly; one that's too soft can deform and leak. Our spec calls for 45 +/- 5 Shore A. Verify that number before accepting a batch.)